4.6 Article

Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cardiac & Cardiovascular Systems

Myocardial Mechanics in Patients With Normal LVEF and Diastolic Dysfunction

Christopher M. Bianco et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Article Urology & Nephrology

End Points for Clinical Trials in Primary Hyperoxaluria

Dawn S. Milliner et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Review Cardiac & Cardiovascular Systems

Ejection Fraction Pros and Cons JACC State-of-the-Art Review

Thomas H. Marwick

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Urology & Nephrology

Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells

Donna Arvans et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Review Cardiac & Cardiovascular Systems

A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography

Patrick Collier et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Review Cardiac & Cardiovascular Systems

Left ventricular hypertrophy or storage disease? the incremental value of speckle tracking strain bull's-eye

Antonello D'Andrea et al.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2017)

Article Urology & Nephrology

Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure

Fang Zhao et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Review Cardiac & Cardiovascular Systems

Strain Imaging From Physiology to Practical Applications in Daily Practice

Nishtha Sareen et al.

CARDIOLOGY IN REVIEW (2016)

Article Urology & Nephrology

Urine oxalate biological variation in patients with primary hyperoxaluria

Oliver Clifford-Mobley et al.

UROLITHIASIS (2016)

Article Cardiac & Cardiovascular Systems

Intervendor Variability of Two-Dimensional Strain Using Vendor-Specific and Vendor-Independent Software

Yasufumi Nagata et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)

Article Urology & Nephrology

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria

Xiaojing Tang et al.

KIDNEY INTERNATIONAL (2015)

Review Pharmacology & Pharmacy

Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions

Bodo B. Beck et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)

Article Medicine, Research & Experimental

Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1 beta secretion

Shrikant R. Mulay et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Medicine, General & Internal

Primary Hyperoxaluria

Pierre Cochat et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Gastroenterology & Hepatology

Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter

Marguerite Hatch et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)

Article Urology & Nephrology

Net Intestinal Transport of Oxalate Reflects Passive Absorption and SLC26A6-mediated Secretion

Felix Knauf et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Article Transplantation

Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria

Bernd Hoppe et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)

Review Surgery

LONG-TERM RESULTS OF LIVER TRANSPLANTATION

F. Aberg et al.

SCANDINAVIAN JOURNAL OF SURGERY (2011)

Article Cardiac & Cardiovascular Systems

Cardiac Abnormalities in Primary Hyperoxaluria

Farouk Mookadam et al.

CIRCULATION JOURNAL (2010)

Review Urology & Nephrology

The primary hyperoxalurias

Bernd Hoppe et al.

KIDNEY INTERNATIONAL (2009)

Article Urology & Nephrology

Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1

B. Hoppe et al.

KIDNEY INTERNATIONAL (2006)

Article Urology & Nephrology

Oxalobacter sp reduces urinary oxalate excretion by promoting enteric oxalate secretion

M Hatch et al.

KIDNEY INTERNATIONAL (2006)